Beyond Conventional LBAs: Accelerating Viral Vector Bioanalysis Using Microfluidic Immunoassays with Nanoliter Sample Volumes and Results in One-Hour
Viral vector quantification using conventional immunoassays suffers from narrow dynamic ranges, large sample volumes, and laborious procedures. In this webcast, we present utilization of high-precision, automated microfluidic immunoassays for the quantification of AAV and lentiviral vectors in bioprocessing applications. Examples of the rapid implementation of AAV titer assays are presented for multiple AAV serotypes.
This webinar was presented during Cell Therapy Digital Week hosted by Informa Connect on February 16, 2021.
Rob Durham, PhD
Director of Service and Scientific Support
Gyros Protein Technologies
If you have problems to view the webinar please contact email@example.com